Barclays’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $75.5M | Buy |
214,500
+184,900
| +625% | +$65.9M | 0.02% | 592 |
|
|
2025
Q4 | $9.69M | Buy |
29,600
+26,200
| +771% | +$8.31M | ﹤0.01% | 1701 |
|
|
2025
Q3 | $959K | Sell |
3,400
-100,000
| -97% | -$29M | ﹤0.01% | 3390 |
|
|
2025
Q2 | $28.9M | Buy |
103,400
+62,500
| +153% | +$17.7M | 0.01% | 936 |
|
|
2025
Q1 | $12.7M | Sell |
40,900
-87,100
| -68% | -$25.7M | ﹤0.01% | 1256 |
|
|
2024
Q4 | $33.4M | Buy |
128,000
+49,200
| +62% | +$14.6M | 0.01% | 836 |
|
|
2024
Q3 | $25.4M | Sell |
78,800
-519,200
| -87% | -$170M | 0.01% | 951 |
|
|
2024
Q2 | $187M | Buy |
598,000
+399,500
| +201% | +$117M | 0.06% | 244 |
|
|
2024
Q1 | $56.4M | Buy |
198,500
+70,200
| +55% | +$20.5M | 0.02% | 574 |
|
|
2023
Q4 | $37M | Buy |
128,300
+10,100
| +9% | +$2.75M | 0.01% | 799 |
|
|
2023
Q3 | $31.8M | Buy |
118,200
+34,800
| +42% | +$8.68M | 0.02% | 625 |
|
|
2023
Q2 | $18.5M | Buy |
83,400
+50,200
| +151% | +$11.6M | 0.01% | 753 |
|
|
2023
Q1 | $8.03M | Sell |
33,200
-30,400
| -48% | -$7.46M | ﹤0.01% | 1269 |
|
|
2022
Q4 | $16.7M | Buy |
+63,600
| New | +$17M | 0.01% | 974 |
|
|
2021
Q3 | – | Sell |
-59,200
| Closed | -$14.4M | – | 4731 |
|
|
2021
Q2 | $14.4M | Buy |
59,200
+39,200
| +196% | +$9.64M | 0.01% | 1039 |
|
|
2021
Q1 | $4.98M | Sell |
20,000
-9,400
| -32% | -$2.24M | ﹤0.01% | 1520 |
|
|
2020
Q4 | $6.76M | Buy |
+29,400
| New | +$6.78M | ﹤0.01% | 1349 |
|
|
2020
Q2 | – | Sell |
-45,900
| Closed | -$9.3M | – | 5520 |
|
|
2020
Q1 | $9.3M | Sell |
45,900
-97,800
| -68% | -$21.4M | 0.01% | 1030 |
|
|
2019
Q4 | $34.6M | Sell |
143,700
-117,000
| -45% | -$25.8M | 0.02% | 668 |
|
|
2019
Q3 | $50.4M | Sell |
260,700
-219,800
| -46% | -$42.2M | 0.03% | 460 |
|
|
2019
Q2 | $88.5M | Buy |
480,500
+410,000
| +582% | +$73.4M | 0.05% | 298 |
|
|
2019
Q1 | $13.4M | Sell |
70,500
-21,400
| -23% | -$4.09M | 0.01% | 1049 |
|
|
2018
Q4 | $17.9M | Sell |
91,900
-55,200
| -38% | -$10.8M | 0.01% | 803 |
|
|
2018
Q3 | $30.5M | Sell |
147,100
-19,600
| -12% | -$3.86M | 0.02% | 642 |
|
|
2018
Q2 | $30.8M | Buy |
166,700
+32,000
| +24% | +$5.66M | 0.03% | 572 |
|
|
2018
Q1 | $23M | Sell |
134,700
-24,700
| -15% | -$4.53M | 0.02% | 786 |
|
|
2017
Q4 | $27.7M | Sell |
159,400
-95,900
| -38% | -$17M | 0.02% | 640 |
|
|
2017
Q3 | $47.6M | Buy |
255,300
+52,300
| +26% | +$9.27M | 0.05% | 311 |
|
|
2017
Q2 | $35M | Sell |
203,000
-33,300
| -14% | -$5.42M | 0.04% | 389 |
|
|
2017
Q1 | $38.8M | Buy |
236,300
+74,700
| +46% | +$12.4M | 0.04% | 325 |
|
|
2016
Q4 | $23.6M | Sell |
161,600
-20,700
| -11% | -$3.12M | 0.03% | 523 |
|
|
2016
Q3 | $30.4M | Buy |
182,300
+71,100
| +64% | +$12M | 0.03% | 391 |
|
|
2016
Q2 | $16.9M | Sell |
111,200
-10,000
| -8% | -$1.55M | 0.02% | 589 |
|
|
2016
Q1 | $18.1M | Sell |
121,200
-182,600
| -60% | -$27.1M | 0.03% | 510 |
|
|
2015
Q4 | $49.2M | Sell |
303,800
-18,600
| -6% | -$2.92M | 0.06% | 286 |
|
|
2015
Q3 | $44.5M | Buy |
322,400
+9,300
| +3% | +$1.47M | 0.05% | 309 |
|
|
2015
Q2 | $47.9M | Sell |
313,100
-42,900
| -12% | -$6.87M | 0.05% | 303 |
|
|
2015
Q1 | $56.6M | Buy |
356,000
+184,300
| +107% | +$29M | 0.07% | 283 |
|
|
2014
Q4 | $27.3M | Sell |
171,700
-48,900
| -22% | -$7.62M | 0.03% | 607 |
|
|
2014
Q3 | $30.9M | Buy |
220,600
+40,400
| +22% | +$5.27M | 0.03% | 519 |
|
|
2014
Q2 | $21.3M | Sell |
180,200
-136,900
| -43% | -$15.8M | 0.02% | 663 |
|
|
2014
Q1 | $39M | Buy |
317,100
+123,700
| +64% | +$15M | 0.04% | 376 |
|
|
2013
Q4 | $22M | Buy |
193,400
+53,200
| +38% | +$6.05M | 0.02% | 719 |
|
|
2013
Q3 | $15.6M | Buy |
140,200
+20,500
| +17% | +$2.22M | 0.02% | 829 |
|
|
2013
Q2 | $11.8M | Buy |
+119,700
| New | +$12.4M | 0.01% | 966 |
|
Other funds holding AMGN
VCM
VPM
Barclays's AMGN Position: Q1 2026 in Review
Barclays reduced its Amgen (AMGN) stake by 20% in Q1 2026, selling an estimated $139M and leaving 1,529,613 shares worth $538M. The position accounts for 0.13% of the portfolio, ranked #119.
Barclays first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.23B in Q1 2024. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Barclays held 1,529,613 shares of Amgen worth $538M as of Q1 2026.
- Barclays sold 390,882 Amgen shares in Q1 2026, an estimated $139M.
- Amgen made up 0.13% of Barclays's portfolio in Q1 2026, its #119 holding.
- Barclays first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
- Barclays's Amgen position peaked at $1.23B in Q1 2024.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.